Editorial: Immunity in the development of anti-cancer drug resistance
Ya Meng,
Haitao Wang,
Xuebing Li,
Xinwei Wu,
Heng Sun,
Heng Sun,
Heng Sun
Affiliations
Ya Meng
Guangdong Provincial Key Laboratory of Tumor Interventional Diagnosis and Treatment, Zhuhai People's Hospital, Zhuhai Hospital Affiliated With Jinan University, Zhuhai, China
Haitao Wang
Thoracic Surgery Branch, Center for Cancer Research, National Cancer Institute (NCI), Bethesda, MD, United States
Xuebing Li
Tianjin Key Laboratory of Lung Cancer Metastasis and Tumor Microenvironment, Tianjin Lung Cancer Institute, Department of Lung Cancer Surgery, Tianjin Medical University General Hospital, Tianjin, China
Xinwei Wu
Thoracic Surgery Branch, Center for Cancer Research, National Cancer Institute (NCI), Bethesda, MD, United States
Heng Sun
Cancer Center, Faculty of Health Sciences, University of Macau, Macau, Macau SAR, China
Heng Sun
MOE Frontiers Science Center for Precision Oncology, University of Macau, Macau, Macau SAR, China
Heng Sun
Zhuhai Research Institute, University of Macau, Zhuhai, Macau SAR, China
